This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this book Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Avruch, J. Articles by Zhang, X.-F. Search for Related Content PubMed PubMed Citation Articles by Avruch, J. Articles by Zhang, X.-F.

Ras Activation of the Raf Kinase

Tyrosine Kinase Recruitment of the MAP Kinase Cascade

Joseph Avruch^*,, Andrei Khokhlatchev^*,, John M. Kyriakis^*, Zhijun Luo, Guri Tzivion, Demetrios Vavvas and Xian-Feng Zhang^*

^* Diabetes Unit and Medical Services
Department of Molecular Biology, Massachusetts General Hospital and the Department of Medicine, Harvard Medical School, Boston, Massachusetts 02114
Boston Medical Center, Boston, Massachusetts 02118
Boston University Medical School, Boston, Massachusetts 02118

ABSTRACT

A continuing focus of our work has been an effort to understand the signal transduction pathways through which insulin achieves its cellular actions. In the mid-1970s, we and others observed that insulin promoted an increase in Ser/Thr phosphorylation of a subset of cellular proteins. This finding was unanticipated, inasmuch as nearly all of the actions of insulin then known appeared to result from protein dephosphorylation. In fact, nearly 15 years elapsed before any physiologic response to insulin attributable to stimulated (Ser/Thr) phosphorylation was established. Nevertheless, based on the hypothesis that insulin-stimulated Ser/Thr phosphorylation reflected the activation of protein (Ser/Thr) kinases downstream of the insulin receptor, we sought to detect and purify these putative, insulin-responsive protein (Ser/Thr) kinases. Our effort was based on the presumption that an understanding of the mechanism for their activation would provide an entry into the biochemical reactions through which the insulin receptor activated its downstream effectors. To a degree that, in retrospect, is surprising, this goal was accomplished, much in the way originally envisioned. It is now well known that receptor tyrosine kinases (RTKs) recruit a large network of protein (Ser/Thr) kinases to execute their cellular programs. The first of these insulin-activated protein kinase networks to be fully elucidated was the Ras-Raf-mitogen-activated protein kinase (MAPK) cascade. This pathway is a central effector of cellular differentiation in development; moreover, its inappropriate and continuous activation provides a potent promitogenic force and is a very common occurrence in human cancers. Conversely, this pathway contributes minimally, if at all, to insulin's program of metabolic regulation. Nevertheless, the importance of the Ras-MAPK pathway in metazoan biology and human malignancies has impelled us to an ongoing analysis of the functions and regulation of Ras and Raf. This chapter will summarize briefly the way in which work from this and other laboratories on insulin signaling led to the discovery of the mammalian MAP kinase cascade and, in turn, to the identification of unique role of the Raf kinases in RTK activation of this protein (Ser/Thr) kinase cascade. We will then review in more detail current understanding of the biochemical mechanism through which the Ras proto-on-cogene, in collaboration with the 14-3-3 protein and other protein kinases, initiates activation of the Raf kinase.

This article has been cited by other articles:

				J. Avruch, R. Xavier, N. Bardeesy, X.-f. Zhang, M. Praskova, D. Zhou, and F. Xia Rassf Family of Tumor Suppressor Polypeptides J. Biol. Chem., April 24, 2009; 284(17): 11001 - 11005. [Abstract] [Full Text] [PDF]

				M. Nakamura, B. Han, T. Nishishita, Y. Bai, and K. Kakudo Calcitonin targets extracellular signal-regulated kinase signaling pathway in human cancers J. Mol. Endocrinol., December 1, 2007; 39(6): 375 - 384. [Abstract] [Full Text] [PDF]

				A. Fischer, M. Hekman, J. Kuhlmann, I. Rubio, S. Wiese, and U. R. Rapp B- and C-RAF Display Essential Differences in Their Binding to Ras: THE ISOTYPE-SPECIFIC N TERMINUS OF B-RAF FACILITATES RAS BINDING J. Biol. Chem., September 7, 2007; 282(36): 26503 - 26516. [Abstract] [Full Text] [PDF]

				D. H. Kumbar, A. VanBergen, C. Ocampo, S. Muangmingsuk, A. J. Griffin, and M. Gupta Adapter molecule DOC-2 is differentially expressed in pressure and volume overload hypertrophy and inhibits collagen synthesis in cardiac fibroblasts J Appl Physiol, May 1, 2007; 102(5): 2024 - 2032. [Abstract] [Full Text] [PDF]

				M Niedziela Pathogenesis, diagnosis and management of thyroid nodules in children. Endocr. Relat. Cancer, June 1, 2006; 13(2): 427 - 453. [Abstract] [Full Text] [PDF]

				V. Balan, D. T. Leicht, J. Zhu, K. Balan, A. Kaplun, V. Singh-Gupta, J. Qin, H. Ruan, M. J. Comb, and G. Tzivion Identification of Novel In Vivo Raf-1 Phosphorylation Sites Mediating Positive Feedback Raf-1 Regulation by Extracellular Signal-regulated Kinase Mol. Biol. Cell, March 1, 2006; 17(3): 1141 - 1153. [Abstract] [Full Text] [PDF]

				J. Xu, A. B. Keeton, J. L. Franklin, X. Li, D. Y. Venable, S. J. Frank, and J. L. Messina Insulin Enhances Growth Hormone Induction of the MEK/ERK Signaling Pathway J. Biol. Chem., January 13, 2006; 281(2): 982 - 992. [Abstract] [Full Text] [PDF]

				V. Emuss, M. Garnett, C. Mason, The Cancer Genome Project, and R. Marais Mutations of C-RAF Are Rare in Human Cancer because C-RAF Has a Low Basal Kinase Activity Compared with B-RAF Cancer Res., November 1, 2005; 65(21): 9719 - 9726. [Abstract] [Full Text] [PDF]

				J. Zhu, V. Balan, A. Bronisz, K. Balan, H. Sun, D. T. Leicht, Z. Luo, J. Qin, J. Avruch, and G. Tzivion Identification of Raf-1 S471 as a Novel Phosphorylation Site Critical for Raf-1 and B-Raf Kinase Activities and for MEK Binding Mol. Biol. Cell, October 1, 2005; 16(10): 4733 - 4744. [Abstract] [Full Text] [PDF]

				M. Beeram, A. Patnaik, and E. K. Rowinsky Raf: A Strategic Target for Therapeutic Development Against Cancer J. Clin. Oncol., September 20, 2005; 23(27): 6771 - 6790. [Abstract] [Full Text] [PDF]

				E. P. Araujo, C. T. De Souza, A. L. Gasparetti, M. Ueno, A. C. Boschero, M. J. A. Saad, and L. A. Velloso Short-Term in Vivo Inhibition of Insulin Receptor Substrate-1 Expression Leads to Insulin Resistance, Hyperinsulinemia, and Increased Adiposity Endocrinology, March 1, 2005; 146(3): 1428 - 1437. [Abstract] [Full Text] [PDF]

				E. O'Neill, L. Rushworth, M. Baccarini, and W. Kolch Role of the Kinase MST2 in Suppression of Apoptosis by the Proto-Oncogene Product Raf-1 Science, December 24, 2004; 306(5705): 2267 - 2270. [Abstract] [Full Text] [PDF]

				A. W. Harmon, D. S. Paul, and Y. M. Patel MEK inhibitors impair insulin-stimulated glucose uptake in 3T3-L1 adipocytes Am J Physiol Endocrinol Metab, October 1, 2004; 287(4): E758 - E766. [Abstract] [Full Text] [PDF]

				J. Lima, V. Trovisco, P. Soares, V. Maximo, J. Magalhaes, G. Salvatore, M. Santoro, T. Bogdanova, M. Tronko, A. Abrosimov, et al. BRAF Mutations Are Not a Major Event in Post-Chernobyl Childhood Thyroid Carcinomas J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4267 - 4271. [Abstract] [Full Text] [PDF]

				I. S. Harris, S. Zhang, I. Treskov, A. Kovacs, C. Weinheimer, and A. J. Muslin Raf-1 Kinase Is Required for Cardiac Hypertrophy and Cardiomyocyte Survival in Response to Pressure Overload Circulation, August 10, 2004; 110(6): 718 - 723. [Abstract] [Full Text] [PDF]

				C. Chen and A. J. Sytkowski Erythropoietin regulation of Raf-1 and MEK: evidence for a Ras-independent mechanism Blood, July 1, 2004; 104(1): 73 - 80. [Abstract] [Full Text] [PDF]

				A. P. Myers, L. B. Corson, J. Rossant, and J. C. Baker Characterization of Mouse Rsk4 as an Inhibitor of Fibroblast Growth Factor-RAS-Extracellular Signal-Regulated Kinase Signaling Mol. Cell. Biol., May 15, 2004; 24(10): 4255 - 4266. [Abstract] [Full Text] [PDF]

				Y. Cohen, E. Rosenbaum, S. Begum, D. Goldenberg, C. Esche, O. Lavie, D. Sidransky, and W. H. Westra Exon 15 BRAF Mutations Are Uncommon in Melanomas Arising in Nonsun-Exposed Sites Clin. Cancer Res., May 15, 2004; 10(10): 3444 - 3447. [Abstract] [Full Text] [PDF]

				Y. Cohen, E. Rosenbaum, D. P. Clark, M. A. Zeiger, C. B. Umbricht, R. P. Tufano, D. Sidransky, and W. H. Westra Mutational Analysis of BRAF in Fine Needle Aspiration Biopsies of the Thyroid: A Potential Application for the Preoperative Assessment of Thyroid Nodules Clin. Cancer Res., April 15, 2004; 10(8): 2761 - 2765. [Abstract] [Full Text] [PDF]

				R. Dvorsky, L. Blumenstein, I. R. Vetter, and M. R. Ahmadian Structural Insights into the Interaction of ROCKI with the Switch Regions of RhoA J. Biol. Chem., February 20, 2004; 279(8): 7098 - 7104. [Abstract] [Full Text] [PDF]

				Y. Zagar, G. Chaumaz, and M. Lieberherr Signaling Cross-talk from G{beta}4 Subunit to Elk-1 in the Rapid Action of Androgens J. Biol. Chem., January 23, 2004; 279(4): 2403 - 2413. [Abstract] [Full Text] [PDF]

				P. H. Sugden Ras, Akt, and Mechanotransduction in the Cardiac Myocyte Circ. Res., December 12, 2003; 93(12): 1179 - 1192. [Abstract] [Full Text] [PDF]

				T. Ikenoue, Y. Hikiba, F. Kanai, Y. Tanaka, J. Imamura, T. Imamura, M. Ohta, H. Ijichi, K. Tateishi, T. Kawakami, et al. Functional Analysis of Mutations within the Kinase Activation Segment of B-Raf in Human Colorectal Tumors Cancer Res., December 1, 2003; 63(23): 8132 - 8137. [Abstract] [Full Text] [PDF]

				N. Dumaz and R. Marais Protein Kinase A Blocks Raf-1 Activity by Stimulating 14-3-3 Binding and Blocking Raf-1 Interaction with Ras J. Biol. Chem., August 8, 2003; 278(32): 29819 - 29823. [Abstract] [Full Text] [PDF]

				Y. Cohen, N. Goldenberg-Cohen, P. Parrella, I. Chowers, S. L. Merbs, J. Pe'er, and D. Sidransky Lack of BRAF Mutation in Primary Uveal Melanoma Invest. Ophthalmol. Vis. Sci., July 1, 2003; 44(7): 2876 - 2878. [Abstract] [Full Text] [PDF]

				F. Nicolaou, J. M. Teodoridis, H. Park, A. Georgakis, O. C. Farokhzad, E. P. Bottinger, N. Da Silva, P. Rousselot, C. Chomienne, K. Ferenczi, et al. CD11c gene expression in hairy cell leukemia is dependent upon activation of the proto-oncogenes ras and junD Blood, May 15, 2003; 101(10): 4033 - 4041. [Abstract] [Full Text] [PDF]

				S. Pattingre, C. Bauvy, and P. Codogno Amino Acids Interfere with the ERK1/2-dependent Control of Macroautophagy by Controlling the Activation of Raf-1 in Human Colon Cancer HT-29 Cells J. Biol. Chem., May 2, 2003; 278(19): 16667 - 16674. [Abstract] [Full Text] [PDF]

				Y. Cohen, M. Xing, E. Mambo, Z. Guo, G. Wu, B. Trink, U. Beller, W. H. Westra, P. W. Ladenson, and D. Sidransky BRAF Mutation in Papillary Thyroid Carcinoma J Natl Cancer Inst, April 16, 2003; 95(8): 625 - 627. [Abstract] [Full Text] [PDF]

				L. M. Fedorov, O. Yu. Tyrsin, T. Papadopoulos, G. Camarero, R. Gotz, and U. R. Rapp Bcl-2 Determines Susceptibility to Induction of Lung Cancer by Oncogenic CRaf Cancer Res., November 1, 2002; 62(21): 6297 - 6303. [Abstract] [Full Text] [PDF]

				A. M. Madiehe, S. Hebert, T. D. Mitchell, and R. B. S. Harris Strain-Dependent Stimulation of Growth in Leptin-Treated Obese db/db Mice Endocrinology, October 1, 2002; 143(10): 3875 - 3883. [Abstract] [Full Text] [PDF]

				Y. Light, H. Paterson, and R. Marais 14-3-3 Antagonizes Ras-Mediated Raf-1 Recruitment to the Plasma Membrane To Maintain Signaling Fidelity Mol. Cell. Biol., July 15, 2002; 22(14): 4984 - 4996. [Abstract] [Full Text] [PDF]

				N. Dumaz, Y. Light, and R. Marais Cyclic AMP Blocks Cell Growth through Raf-1-Dependent and Raf-1-Independent Mechanisms Mol. Cell. Biol., June 1, 2002; 22(11): 3717 - 3728. [Abstract] [Full Text] [PDF]

				A. Hindley and W. Kolch Extracellular signal regulated kinase (ERK)/mitogen activated protein kinase (MAPK)-independent functions of Raf kinases J. Cell Sci., April 15, 2002; 115(8): 1575 - 1581. [Abstract] [Full Text] [PDF]

				M. Zang, C. Hayne, and Z. Luo Interaction between Active Pak1 and Raf-1 Is Necessary for Phosphorylation and Activation of Raf-1 J. Biol. Chem., February 1, 2002; 277(6): 4395 - 4405. [Abstract] [Full Text] [PDF]